← Back to headlines
Eli Lilly Pledges US$3 Billion Investment to Expand China Supply Chain
Eli Lilly has committed an additional US$3 billion investment in China over the next decade to enhance its local supply chain and manufacturing capabilities, anticipating approval for its drug orforglipron.
11 Mar, 13:39 — 11 Mar, 15:31
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center1
Center (1)
SCMP
Right
Far R
Geographic diversity— 2 regions9/34
US1Hong Kong1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
SCMPMostly Factual32d ago
Eli Lilly boosts China footprint with US$3 billion plan to expand supply chain
Eli Lilly has pledged an additional US$3 billion investment in China over the next decade to strengthen its local supply chain and manufacturing capabilities, deepening the footprint of foreign pharmaceutical giants in the world’s second-largest healthcare market. The move would bring the total cumulative investment of Eli Lilly, the world’s largest pharmaceutical company by market capitalisation, in China to nearly US$6 billion, according to a statement released on its WeChat account on...
By Themis Qi,Julie Zhang
Read full article →YahooMostly Factual32d ago
Eli Lilly to invest $3bn in China in anticipation of orforglipron approval
Read full article →Coverage Timeline
First report: SCMP · 11 Mar, 13:39|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning
